Licochalcone A selectively modulates mTORC1‐TFEB to enhance autophagy and demonstrates neuroprotective effects in a mouse model of Parkinson's disease
Abstract Activation of transcription factor EB (TFEB), a key regulator of autophagy induction and lysosomal biogenesis, is considered a promising therapeutic strategy for treating the currently incurable Parkinson's disease (PD). However, most TFEB activators also inhibit mTORC1, which regulate...
Saved in:
| Main Authors: | Sisi Wang, Ziyang Ding, Zhou Zhu, Xiaoru Zhong, Ashok Iyaswamy, Yaping Niu, Wei Zhang, Jichao Sun, Yulin Feng, Chuanbin Yang, Jigang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Brain-X |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brx2.70031 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
L-Ergothioneine ameliorates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease in C57BL/6J mice by activating DJ-1
by: Xianshe Meng, et al.
Published: (2025-03-01) -
TXNIP deficiency attenuates renal fibrosis by modulating mTORC1/TFEB-mediated autophagy in diabetic kidney disease
by: Yunxia Du, et al.
Published: (2024-12-01) -
Effect of levodopa and clioquinol on antioxidant capacity in Parkinson’s disease rhesus monkeys
by: LI Like, et al.
Published: (2017-05-01) -
Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation
by: Reini E N van der Welle, et al.
Published: (2021-04-01) -
Date preliminare privind unele manifestări ale durerii într-un model de șobolan MPTP-indus a bolii Parkinson
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)